Works by Fathi, Amir

Results: 132
    1
    2
    3
    4
    5

    A nonrandomized phase I and biomarker trial of regorafenib in advanced myeloid malignancies.

    Published in:
    EJHaem, 2022, v. 3, n. 2, p. 434, doi. 10.1002/jha2.408
    By:
    • How, Joan;
    • Ren, Siyang;
    • Lombardi‐Story, Jennifer;
    • Bergeron, Meghan;
    • Foster, Julia;
    • Amrein, Phillip C.;
    • Brunner, Andrew M.;
    • Fathi, Amir T.;
    • Hock, Hanno;
    • Khachatryan, Anna;
    • Kikuchi, Hiroto;
    • Ng, Mei Rosa;
    • Moran, Jenna;
    • Narayan, Rupa;
    • Neuberg, Donna;
    • Ramos, Aura;
    • Som, Tina;
    • Vartanian, Meghan;
    • Chen, Yi‐Bin;
    • Duda, Dan G.
    Publication type:
    Article
    6
    7
    8

    Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia.

    Published in:
    Oncologist, 2019, v. 24, n. 2, p. 247, doi. 10.1634/theoncologist.2018-0317
    By:
    • El‐Jawahri, Areej;
    • Nelson‐Lowe, Margaret;
    • VanDusen, Harry;
    • Traeger, Lara;
    • Abel, Gregory A.;
    • Greer, Joseph A.;
    • Fathi, Amir;
    • Steensma, David P.;
    • LeBlanc, Thomas W.;
    • Li, Zhigang;
    • DeAngelo, Daniel;
    • Wadleigh, Martha;
    • Hobbs, Gabriela;
    • Foster, Julia;
    • Brunner, Andrew;
    • Amrein, Philip;
    • Stone, Richard M.;
    • Temel, Jennifer S.
    Publication type:
    Article
    9

    Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.

    Published in:
    Oncologist, 2016, v. 21, n. 2, p. 214, doi. 10.1634/theoncologist.2015-0342
    By:
    • Fathi, Amir T.;
    • Nahed, Brian V.;
    • Wander, Seth A.;
    • Iafrate, A. John;
    • Borger, Darrell R.;
    • Hu, Ranliang;
    • Thabet, Ashraf;
    • Cahill, Daniel P.;
    • Perry, Ashley M.;
    • Joseph, Christelle P.;
    • Muzikansky, Alona;
    • Chi, Andrew S.
    Publication type:
    Article
    10
    11
    12

    Factors Associated with Health Care Utilization at the End of Life for Patients with Acute Myeloid Leukemia.

    Published in:
    Journal of Palliative Medicine, 2022, v. 25, n. 5, p. 749, doi. 10.1089/jpm.2021.0249
    By:
    • Vaughn, Dagny M.;
    • Johnson, P. Connor;
    • Jagielo, Annemarie D.;
    • Topping, Carlisle E.W.;
    • Reynolds, Matthew J.;
    • Kavanaugh, Alison R.;
    • Webb, Jason A.;
    • Fathi, Amir T.;
    • Hobbs, Gabriela;
    • Brunner, Andrew;
    • O'Connor, Nina;
    • Luger, Selina;
    • Bhatnagar, Bhavana;
    • LeBlanc, Thomas W.;
    • El-Jawahri, Areej
    Publication type:
    Article
    13
    14
    15
    16
    17

    Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 9, p. E233, doi. 10.1002/ajh.27005
    By:
    • DiNardo, Courtney D.;
    • De Botton, Stéphane;
    • Pollyea, Daniel A.;
    • Stone, Richard M.;
    • Altman, Jessica K.;
    • Fathi, Amir T.;
    • Limsakun, Tharin;
    • Liang, Min;
    • Choe, Sung;
    • Hossain, Mohammad;
    • Tron, Adriana E.;
    • Meng, Qian;
    • Kapsalis, Stephanie M.;
    • Pandya, Shuchi S.;
    • Stein, Eytan M.
    Publication type:
    Article
    18
    19
    20
    21
    22

    A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.

    Published in:
    American Journal of Hematology, 2018, v. 93, n. 2, p. 254, doi. 10.1002/ajh.24968
    By:
    • DeAngelo, Daniel J.;
    • Brunner, Andrew M.;
    • Werner, Lillian;
    • Avigan, David;
    • Fathi, Amir T.;
    • Sperling, Adam S.;
    • Washington, Abigail;
    • Stroopinsky, Dina;
    • Rosenblatt, Jacalyn;
    • McMasters, Malgorzata;
    • Luptakova, Katarina;
    • Wadleigh, Martha;
    • Steensma, David P.;
    • Hobbs, Gabriela S.;
    • Attar, Eyal C.;
    • Amrein, Philip C.;
    • Ebert, Benjamin L.;
    • Stone, Richard M.;
    • Ballen, Karen K.
    Publication type:
    Article
    23
    24
    25
    26
    27

    Isocitrate Dehydrogenase 1 (IDH1) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-Hydroxyglutarate.

    Published in:
    Oncologist, 2014, v. 19, n. 6, p. 602, doi. 10.1634/theoncologist.2013-0417
    By:
    • Fathi, Amir T.;
    • Sadrzadeh, Hossein;
    • Comander, Amy H.;
    • Higgins, Michaela J.;
    • Bardia, Aditya;
    • Perry, Ashley;
    • Burke, Meghan;
    • Silver, Regina;
    • Matulis, Christina R.;
    • Straley, Kimberly S.;
    • Yen, Katharine E.;
    • Agresta, Sam;
    • Kim, Hyeryun;
    • Schenkein, David P.;
    • Borger, Darrell R.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.

    Published in:
    2018
    By:
    • Emadi, Ashkan;
    • Law, Jennie Y.;
    • Strovel, Erin T.;
    • Lapidus, Rena G.;
    • Jeng, Linda J. B.;
    • Lee, Myounghee;
    • Blitzer, Miriam G.;
    • Carter-Cooper, Brandon A.;
    • Sewell, Danielle;
    • Van Der Merwe, Isabella;
    • Philip, Sunita;
    • Imran, Mohammad;
    • Yu, Stephen L.;
    • Li, Hongxia;
    • Amrein, Philip C.;
    • Duong, Vu H.;
    • Sausville, Edward A.;
    • Baer, Maria R.;
    • Fathi, Amir T.;
    • Singh, Zeba
    Publication type:
    journal article
    38
    39

    P724: UPDATED SUBSTUDY RESULTS FOR IVOSIDENIB IN IDH1‐MUTANT RELAPSED/REFRACTORY MYELODYSPLASTIC SYNDROME.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000969800.75740.ab
    By:
    • Dinardo, Courtney;
    • Roboz, Gail;
    • M. Watts, Justin;
    • Madanat, Yazan;
    • T Prince, Gabrielle;
    • Baratam, Praneeth;
    • de Botton, Stéphane;
    • Stein, Anthony;
    • M Foran, James;
    • L Arellano, Martha;
    • Sallman, David;
    • M Marchione, Dylan;
    • Bai, Xiaofei;
    • A Patel, Prapti;
    • M Kapsalis, Stephanie;
    • Garcia‐Manero, Guillermo;
    • Fathi, Amir
    Publication type:
    Article
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy.

    Published in:
    2020
    By:
    • Shallis, Rory M.;
    • Stahl, Maximilian;
    • Wei, Wei;
    • Montesinos, Pau;
    • Lengline, Etienne;
    • Neukirchen, Judith;
    • Bhatt, Vijaya R.;
    • Sekeres, Mikkael A.;
    • Fathi, Amir T.;
    • Konig, Heiko;
    • Luger, Selina;
    • Khan, Irum;
    • Roboz, Gail J.;
    • Cluzeau, Thomas;
    • Martínez-Cuadron, David;
    • Raffoux, Emmanuel;
    • Germing, Ulrich;
    • Umakanthan, Jayadev Manikkam;
    • Mukhereje, Sudipto;
    • Brunner, Andrew M.
    Publication type:
    Letter
    49
    50

    Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 1, p. 246, doi. 10.1080/10428194.2018.1468893
    By:
    • Stahl, Maximilian;
    • DeVeaux, Michelle;
    • Montesinos, Pau;
    • Itzykson, Raphaël;
    • Ritchie, Ellen K.;
    • Sekeres, Mikkael A.;
    • Barnard, John;
    • Podoltsev, Nikolai A.;
    • Brunner, Andrew;
    • Komrokji, Rami S.;
    • Bhatt, Vijaya R.;
    • Al-Kali, Aref;
    • Cluzeau, Thomas;
    • Santini, Valeria;
    • Roboz, Gail J.;
    • Fenaux, Pierre;
    • Litzow, Mark;
    • Fathi, Amir T.;
    • Perreault, Sarah;
    • Kim, Tae Kon
    Publication type:
    Article